Clearance Summary
NXSTAGE THERAPY SYSTEM received FDA 510(k) clearance under submission number K020858, sponsored by Nxstage Medical, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2002-04-17.
- Submission: K020858
- Applicant / Sponsor: Nxstage Medical, Inc.
- Clearance pathway: Special
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5860
- Decision date: 2002-04-17
Classification & Regulation
This clearance is catalogued under FDA product code KDI and 21 CFR 876.5860, within the Gastroenterology, Urology review panel as a Class II device.